These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37748953)

  • 1. Corrigendum to "EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma" [J Hepatol (79) (2023) 181-208].
    ;
    J Hepatol; 2023 Nov; 79(5):1342. PubMed ID: 37748953
    [No Abstract]   [Full Text] [Related]  

  • 2. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.
    ;
    J Hepatol; 2023 Jul; 79(1):181-208. PubMed ID: 37084797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma" [J Hepatol 69 (2018) 182-236].
    European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
    J Hepatol; 2019 Apr; 70(4):817. PubMed ID: 30739718
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "EASL clinical practice guidelines on the management of hepatic encephalopathy" [J Hepatol 2022 (77) 807-824].
    ;
    J Hepatol; 2023 Nov; 79(5):1340. PubMed ID: 37758523
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis" [J Hepatol 69 (2018) 406-460].
    ;
    J Hepatol; 2018 Nov; 69(5):1207. PubMed ID: 30172388
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "EASL clinical practice guidelines on the management of cystic liver diseases" [J Hepatol (77) 1083-1108].
    ;
    J Hepatol; 2023 Nov; 79(5):1338. PubMed ID: 37726183
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "EASL Clinical Practice Guidelines on haemochromatosis" [J Hepatol 2022 (77) 479-502].
    ;
    J Hepatol; 2023 Nov; 79(5):1341. PubMed ID: 37770291
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "EASL clinical practice guidelines on sclerosing cholangitis" [J Hepatol (77) 761-806].
    ;
    J Hepatol; 2023 Nov; 79(5):1339. PubMed ID: 37735011
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to 'EASL recommendations on treatment of hepatitis C: Final update of the series
    European Association For The Study Of The Liver
    J Hepatol; 2023 Feb; 78(2):452. PubMed ID: 36464532
    [No Abstract]   [Full Text] [Related]  

  • 10. Erratum to "EASL Clinical Practice Guidelines on acute-on-chronic liver failure" [J Hepatol 79 (2023) 461-491].
    ;
    J Hepatol; 2024 Aug; 81(2):370. PubMed ID: 38772794
    [No Abstract]   [Full Text] [Related]  

  • 11. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
    Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.
    Fong ZV; Brownlee SA; Qadan M; Tanabe KK
    Ann Surg Oncol; 2021 May; 28(5):2660-2674. PubMed ID: 33646431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI)" [J Clin Exp Hepatol 9 (2019) 74-98].
    Nagral A; Sarma MS; Matthai J; Kukkle PL; Devarbhavi H; Sinha S; Alam S; Bavdekar A; Dhiman RK; Eapen CE; Goyal V; Mohan N; Kandadai RM; Sathiyasekaran M; Poddar U; Sibal A; Sankaranarayanan S; Srivastava A; Thapa BR; Wadia PM; Yachha SK; Dhawan A
    J Clin Exp Hepatol; 2020; 10(1):99. PubMed ID: 32025169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic cholangiocarcinoma.
    Nakano M; Ariizumi SI; Yamamoto M
    Semin Diagn Pathol; 2017 Mar; 34(2):160-166. PubMed ID: 28094162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
    Mouli S; Memon K; Baker T; Benson AB; Mulcahy MF; Gupta R; Ryu RK; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2013 Aug; 24(8):1227-34. PubMed ID: 23602420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.
    Bridgewater J; Galle PR; Khan SA; Llovet JM; Park JW; Patel T; Pawlik TM; Gores GJ
    J Hepatol; 2014 Jun; 60(6):1268-89. PubMed ID: 24681130
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to: "Portopulmonary hypertension in the current era of pulmonary hypertension management" [J Hepatol (2020);73:130-139].
    Savale L; Guimas M; Ebstein N; Fertin M; Jevnikar M; Renard S; Horeau-Langlard D; Tromeur C; Chabanne C; Prevot G; Chaouat A; Moceri P; Artaud-Macari É; Degano B; Tresorier R; Boissin C; Bouvaist H; Simon AC; Riou M; Favrolt N; Palat S; Bourlier D; Magro P; Cottin V; Bergot E; Lamblin N; Jaïs X; Coilly A; Durand F; Francoz C; Conti F; Hervé P; Simonneau G; Montani D; Duclos-Vallée JC; Samuel D; Humbert M; De Groote P; Sitbon O
    J Hepatol; 2020 Nov; 73(5):1293-1294. PubMed ID: 32907706
    [No Abstract]   [Full Text] [Related]  

  • 18. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
    Blond E; Disse E; Cuerq C; Drai J; Valette PJ; Laville M; Thivolet C; Simon C; Caussy C
    Diabetologia; 2017 Jul; 60(7):1218-1222. PubMed ID: 28352941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.
    Aabakken L; Karlsen TH; Albert J; Arvanitakis M; Chazouilleres O; Dumonceau JM; Färkkilä M; Fickert P; Hirschfield GM; Laghi A; Marzioni M; Fernandez M; Pereira SP; Pohl J; Poley JW; Ponsioen CY; Schramm C; Swahn F; Tringali A; Hassan C
    Endoscopy; 2017 Jun; 49(6):588-608. PubMed ID: 28420030
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Ferroportin disease: A systematic meta-analysis of clinical and molecular findings" J. Hepatol. 2010 Nov;53(5):941-949.
    Mayr R; Janecke AR; Schranz M; Griffiths WJH; Vogel W; Pietrangelo A; Zoller H
    J Hepatol; 2011 Sep; 55(3):734-736. PubMed ID: 28843946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.